In this episode of PayerTalkCE®, we will delve into the innovations around HER2-targeting therapies and their role in the treatment of select gastrointestinal cancers. Topics will include the latest evidence and the integration of new treatments into health care systems, insurance coverage, reimbursement challenges, and the overall impact on health care policy.

This activity is certified for CME/CNE/CPE credit. To participate and earn 

credit, visit us at https://www.impactedu.net/gi-cancer-ce/.

In this episode of PayerTalkCE® we will explore the epidemiology and burdens of gastroesophageal and biliary tract cancers. Experts will discuss the importance of early and accurate diagnosis in managing treatment efficacy and cost. The episode will also delve into the role of personalized medicine and multidisciplinary approaches and provide collaborative and actionable insights on how managed care professionals can adapt their strategies to better accommodate the complexities associated with rare GI cancers, ultimately aiming to enhance patient care while managing resource allocation effectively.

This activity is certified for CME/CNE/CPE credit. To participate and earn 

credit, visit us at https://www.impactedu.net/gi-trends-ce/.

This podcast explores macular telangiectasia (MacTel), a rare and progressive retinal disease, with a focus on advancing early detection, appropriate treatment, and health system coordination. Retina specialist Dr. Jay Chhablani discusses the shift in understanding MacTel as a neurodegenerative—not vascular—condition, highlighting the limitations of anti-VEGF therapy and the significance of a newly approved, durable implant that targets neuroprotection. The discussion outlines the importance of benefit design that facilitates timely access, supports multidisciplinary care, and emphasizes early intervention to prevent irreversible vision loss. Practical payer strategies—including reducing artificial barriers and prioritizing education—are addressed to optimize outcomes.

This activity is certified for CME/CNE/CPE credit. To participate and earn 

credit, visit us at https://www.impactedu.net/mactel-strategies-ce/.

This podcast highlights opportunities for managed care organizations to improve COPD management by aligning coverage policies with current clinical evidence and treatment guidelines. Experts discuss new therapies, including recently approved biologics and inhaled agents, and their roles in treating patients with frequent exacerbations or type 2 inflammation. The session also addresses implementation barriers such as limited spirometry access, inconsistent pulmonary rehab availability, and disparities in care. Strategies for payer engagement include expanding telehealth, integrating social determinants of health data, enhancing care coordination, and supporting multidisciplinary care models to reduce hospitalizations and improve outcomes in patients with moderate to severe COPD.

This activity is certified for CME/CNE/CPE credit. To participate and earn 

credit, visit us at https://www.impactedu.net/type2-inflammation-copd-management-ce/.

This podcast features expert discussion on the emerging role of type 2 (T2) inflammation in chronic obstructive pulmonary disease (COPD) and the implications for payer and provider decision-making. Faculty review key pathophysiologic mechanisms and biomarkers—particularly eosinophil counts—that identify patients most likely to benefit from targeted biologic therapies. The conversation also explores updated GOLD guideline recommendations, strategies to optimize formulary access, the impact of T2 inflammation on long-term outcomes, and opportunities to reduce hospitalizations and oral steroid use. Health plan professionals will gain insights into aligning policies with evolving clinical evidence and enhancing care coordination to improve outcomes.

This activity is certified for CME/CNE/CPE credit. To participate and earn 

credit, visit us at https://www.impactedu.net/type2-inflammation-copd-management/.

This podcast reviews a case-based discussion on managing age-related macular degeneration (AMD), a leading cause of blindness among older adults, particularly those enrolled in Medicare Advantage plans. Experts review the progression of AMD, key diagnostic tools, and the importance of timely anti-VEGF therapy to prevent vision loss. The conversation highlights payer considerations, including step therapy requirements, treatment burden, and long-term cost implications. It also addresses challenges such as healthcare access in rural areas and potential strategies for improving patient adherence and outcomes. The discussion underscores the need for balanced policies that optimize clinical efficacy and economic sustainability.

This activity is certified for CME/CNE/CPE credit. To participate and earn 

credit, visit us at https://www.managedcareeye.com/amd-case-challenge-ce/.

This podcast explores the challenges of managing diabetic retinopathy in patients with type 1 diabetes, focusing on a case study of a working-age patient with barriers to care. Expert insights highlight the importance of early screening, timely intervention, and payer strategies to facilitate access to specialty care. Discussion covers diagnostic approaches, treatment selection, and the role of anti-VEGF therapies, including considerations around step therapy and treatment adherence. The conversation emphasizes the impact of social determinants on care continuity and explores how health plans can improve patient outcomes through streamlined authorization processes and better care coordination within multidisciplinary teams.

This activity is certified for CME/CNE/CPE credit. To participate and earn 

credit, visit us at https://www.managedcareeye.com/t1-diabetes-case/.

This podcast provides health plan professionals with expert insights on best practices for managing moderate to severe asthma, focusing on type 2 inflammation. Discussion topics include current treatment guidelines, the role of biomarkers in therapy selection, and the impact of biologics on reducing exacerbations and healthcare utilization. Experts also examine challenges in asthma management, such as adherence barriers, care fragmentation, and affordability, while highlighting opportunities for payers to support multidisciplinary care and improve patient outcomes. The conversation underscores the importance of collaboration between payers and providers to ensure appropriate utilization of therapies and enhance access to high-quality asthma care.

This activity is certified for CME/CNE/CPE credit. To participate and earn 

credit, visit us at https://www.impactedu.net/type2-inflammation-asthma-management-ce/.

This podcast provides health plan professionals with an in-depth discussion on the role of type 2 (T2) inflammation in asthma pathophysiology and the evolving treatment landscape. Experts explore the mechanisms driving T2 inflammation and how biomarkers can help guide therapy selection. The conversation highlights biologic treatments' clinical and economic considerations, including their impact on reducing exacerbations, optimizing outcomes, and managing healthcare costs. Panelists also discuss payer strategies for ensuring appropriate utilization, balancing financial stewardship with patient access, and the importance of collaboration between payers and providers to improve asthma care and reduce healthcare resource utilization.

This activity is certified for CME/CNE/CPE credit. To participate and earn 

credit, visit us at

https://www.impactedu.net/type2-inflammation-asthma-management-ce/.

This podcast explores payer best practices in managing atopic dermatitis, emphasizing the role of type 2 inflammation and its impact on patient outcomes. Experts discuss current treatment guidelines, the efficacy of emerging therapies, and strategies for tailoring care to patient needs, including those with darker skin tones. Key barriers such as access to dermatologists, treatment complexity, and psychosocial impacts are highlighted, with insights on payer strategies to improve access and affordability. Topics include clinical guidelines, innovative payer programs, formulary management, and value-based contracting to enhance care quality while controlling costs.

This activity is certified for CME/CNE/CPE credit. To participate and earn 

credit, visit us at

https://www.impactedu.net/type2-inflammation-atopic-dermatitis-management-ce/.